ATE203768T1 - Diagnose und behandlung von streptococus oder enterococus infektionen - Google Patents

Diagnose und behandlung von streptococus oder enterococus infektionen

Info

Publication number
ATE203768T1
ATE203768T1 AT95907070T AT95907070T ATE203768T1 AT E203768 T1 ATE203768 T1 AT E203768T1 AT 95907070 T AT95907070 T AT 95907070T AT 95907070 T AT95907070 T AT 95907070T AT E203768 T1 ATE203768 T1 AT E203768T1
Authority
AT
Austria
Prior art keywords
enterococci
diagnosis
treatment
infection due
streptococci
Prior art date
Application number
AT95907070T
Other languages
English (en)
Inventor
James Peter Burnie
Ruth Christine Matthews
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Application granted granted Critical
Publication of ATE203768T1 publication Critical patent/ATE203768T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cookers (AREA)
  • Glass Compositions (AREA)
AT95907070T 1994-01-28 1995-01-30 Diagnose und behandlung von streptococus oder enterococus infektionen ATE203768T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9401689A GB9401689D0 (en) 1994-01-28 1994-01-28 Diagnosis and treatment of endocarditis
PCT/GB1995/000186 WO1995020658A2 (en) 1994-01-28 1995-01-30 Diagnosis and treatment of infections due to streptococci and enterococci

Publications (1)

Publication Number Publication Date
ATE203768T1 true ATE203768T1 (de) 2001-08-15

Family

ID=10749513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95907070T ATE203768T1 (de) 1994-01-28 1995-01-30 Diagnose und behandlung von streptococus oder enterococus infektionen

Country Status (10)

Country Link
US (1) US5861157A (de)
EP (1) EP0740703B1 (de)
JP (1) JP3744937B2 (de)
AT (1) ATE203768T1 (de)
AU (1) AU702144B2 (de)
CA (1) CA2181924C (de)
DE (1) DE69521985T2 (de)
GB (1) GB9401689D0 (de)
NZ (1) NZ278922A (de)
WO (1) WO1995020658A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9614274D0 (en) * 1996-07-06 1996-09-04 Univ Manchester Treatment and diagnosis of infections of gram positive cocci
US6583275B1 (en) 1997-07-02 2003-06-24 Genome Therapeutics Corporation Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
FR2791357B1 (fr) * 1999-03-26 2003-05-16 Didier Raoult Diagnostic de la maladie de whipple
FR2826581B1 (fr) * 2001-06-29 2005-10-07 Oreal Utilisation du tripeptide lys-pro-val (kpv) dans le traitement des melanomes
EP2450053B1 (de) * 2010-11-05 2016-06-15 Universitätsklinikum Freiburg Neuartiges Antigen von Enterokokkenpathogenen und ihre Verwendung als Impfstoffkomponenten für Therapie und/oder Prophylaxe
US11759460B2 (en) 2020-08-14 2023-09-19 Devie Medical Gmbh Method of local antibiotic treatment of infective endocarditis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
WO1990007577A1 (en) * 1988-12-29 1990-07-12 Bio-Technology General Corp. Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs
AU6098994A (en) * 1993-01-27 1994-08-15 Duke University Methods and agents for the diagnosis and treatment of rheumatoid arthritis

Also Published As

Publication number Publication date
CA2181924C (en) 2010-08-24
JPH09509569A (ja) 1997-09-30
JP3744937B2 (ja) 2006-02-15
EP0740703B1 (de) 2001-08-01
GB9401689D0 (en) 1994-03-23
EP0740703A1 (de) 1996-11-06
WO1995020658A2 (en) 1995-08-03
US5861157A (en) 1999-01-19
AU702144B2 (en) 1999-02-11
CA2181924A1 (en) 1995-08-03
WO1995020658A3 (en) 1995-10-19
AU1540795A (en) 1995-08-15
DE69521985T2 (de) 2001-11-15
DE69521985D1 (de) 2001-09-06
NZ278922A (en) 1998-05-27

Similar Documents

Publication Publication Date Title
ATE294864T1 (de) Äusseres membranprotein von haemophilus
DE3686304D1 (de) Typenspezifische papillomavirus-dns-sequenzen und peptide.
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
DE3786200D1 (de) Diagnostische verfahren zum nachweis von lymphomen bei menschen.
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
DE69032598D1 (de) Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden
DK0728200T3 (da) Haemophilus-transferrin-receptorgener
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
DK0494294T3 (da) Bakterielle stressproteiner
FR2795735B1 (fr) Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
ATE203768T1 (de) Diagnose und behandlung von streptococus oder enterococus infektionen
DE69738770D1 (de) Porphyromonas gingivalis Antigene zur Diagnose und Behandlung von Periodontitis
DE3751727D1 (de) Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
DE3879085D1 (de) Snrnp-a-antigen und fragmente davon.
EP0177814A3 (de) Antikörper gegen Peptide und ihre Verwendung zum Nachweis von Onkogene-Produkten
WO1992021697A3 (en) Diagnostic peptides derived from m.tuberculosis antigens
DE69633179D1 (de) Transferrinrezeptorgene
NO962596L (no) Nytt tumorsupressorgen
DE69017352D1 (de) An HIV relatierte Peptide.
WO1995021916A3 (en) Pp32: a newly identified cd45-associated protein
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification